News

Filter

Current filters:

Campath

1 to 9 of 86 results

Sanofi-Aventis confirms it is considering CVR-based deal regarding takeover of Genzyme

10-01-2011

Following intense rumor and speculation over the weekend, late Sunday, French drug major Sanofi-Aventis…

AlemtuzumabBiotechnologyCampathGenzymeLemtradaMergers & AcquisitionsPharmaceuticalSanofi-Aventis

UPDATE: Bayer completes deal to transfer three oncology drugs to Genzyme

03-06-2009

German drug major Bayer HealthCare and USA-based biotechnology group Genzyme have received regulatory…

AlemtuzumabAspirinBayerBayerCampathFludaraFludarabineGenzymeLeukineSargramostim

Bayer transfers three oncology drugs to Genzyme for an initial $650 million

01-04-2009

German pharmaceutical major Bayer has entered into an agreement to transfer part of its oncology portfolio…

AlemtuzumabAspirinBayerBayerCampathFludaraFludarabineGenzymeLeukineNexavarSargramostimSorafenib

1 to 9 of 86 results

Back to top